Italy was the first and among the hardest-hit countries in Europe by the COVID-19 pandemic. Emergency regulation for COVID-19 clinical trials and compassionate uses...more
Due to the COVID-19 emergency and the consequent lockdown that is affecting non-essential services in Italy, including some health care services, on March 12, 2020 the Italian Medicines Agency ("AIFA") issued a Guidance,...more
3/16/2020
/ China ,
Clinical Trials ,
Coronavirus/COVID-19 ,
Crisis Management ,
EU ,
Good Clinical Practices ,
Infectious Diseases ,
Italy ,
Life Sciences ,
Pharmaceutical Industry ,
Public Health